Bis-heteroaryl amide compounds and uses thereof

TW202641513APending Publication Date: 2026-10-16XENON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114150247
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-06-30
Filing Date
2025-12-19
Publication Date
2026-10-16
Patent Text Reader

Abstract

Provided herein are compounds, including compounds of any of the formulae described herein (e.g., Formula (I)), and pharmaceutically acceptable salts, stereoisomers, tautomers, solvates, hydrates, isotopically labeled derivatives, and prodrugs thereof. Compounds provided herein can potentiate Kv7 potassium channels (e.g., Kv7.2 / Kv7.3). In some embodiments, the compounds provided herein are useful in the treatment and / or prevention of diseases, disorders, and conditions (e.g., diseases, disorders, and conditions associated with Kv7 potassium channel dysfunction). In some embodiments, the compounds provided herein target Kv7 voltage-sensing domains (VSDs).
Need to check novelty before this filing date? Find Prior Art